Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
2.510
-0.190 (-7.04%)
Nov 13, 2025, 4:00 PM EST - Market closed
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $580.96 million as of November 14, 2025. Its market cap has increased by 180.87% in one year.
Market Cap
580.96M
Enterprise Value
603.61M
1-Year Change
180.87%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $580.96M, a decrease of -41.63%. That is a compound annual growth rate of -7.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 580.96M | 183.41% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | 701.04M | -26.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 885.19B |
| Johnson & Johnson | 466.99B |
| AbbVie | 397.96B |
| UnitedHealth Group | 296.62B |
| AstraZeneca | 275.02B |
| Novartis AG | 249.68B |
| Merck & Co. | 225.74B |
| Abbott Laboratories | 220.84B |